Common Practice Patterns in the Diagnosis and Management of Acute Retinal Necrosis: A Survey Study of Uveitis Specialists.

IF 2.6 4区 医学 Q2 OPHTHALMOLOGY
Ocular Immunology and Inflammation Pub Date : 2025-07-01 Epub Date: 2024-07-29 DOI:10.1080/09273948.2024.2380902
Isabel K Ray, Lucia Sobrin, Ramana Moorthy, Steven Yeh, Jennifer E Thorne, Jessica G Shantha
{"title":"Common Practice Patterns in the Diagnosis and Management of Acute Retinal Necrosis: A Survey Study of Uveitis Specialists.","authors":"Isabel K Ray, Lucia Sobrin, Ramana Moorthy, Steven Yeh, Jennifer E Thorne, Jessica G Shantha","doi":"10.1080/09273948.2024.2380902","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Due to lack of large randomized clinical trials to determine best practices in treating acute retinal necrosis (ARN), there is not a clear consensus amongst ophthalmologists on how to best manage this potentially blinding condition. The aim of this study is to survey common practice patterns and analyze the factors that affect ophthalmologists' management of ARN.</p><p><strong>Methods: </strong>An anonymous survey was distributed to uveitis and retina specialists who are members of the American Uveitis Society (AUS) via email to query practice patterns regarding ARN. The survey included 22 questions with an additional 10 questions based on response. Survey question topics included demographic information, diagnostic testing, antiviral therapy, corticosteroids, and surgical procedures.</p><p><strong>Results: </strong>67 surveys were included for analysis. Most respondents (87%) always or frequently obtain intraocular aqueous fluid for diagnostic PCR testing. The majority of respondents would administer intravitreal antiviral injections to a unilateral immunocompetent ARN patient (67%), but would be even more likely to do so for a bilateral immunosuppressed ARN patient (87%). Respondents tend to treat ARN with systemic rather than local corticosteroids, with the majority (63%) of respondents initiating corticosteroid treatment 48 hours after treatment. Most respondents (79%) never perform a vitrectomy to manage ARN unless the patient has a retinal detachment or tear. The majority (63%) rarely or never perform prophylactic laser barricade, but may consider laser treatment if there is extensive retinal involvement.</p><p><strong>Conclusion: </strong>Current practice patterns for diagnosis and management of ARN among AUS members generally align with the suggested practices outlined by the American Academy of Ophthalmology.</p>","PeriodicalId":19406,"journal":{"name":"Ocular Immunology and Inflammation","volume":" ","pages":"729-735"},"PeriodicalIF":2.6000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Immunology and Inflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09273948.2024.2380902","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Due to lack of large randomized clinical trials to determine best practices in treating acute retinal necrosis (ARN), there is not a clear consensus amongst ophthalmologists on how to best manage this potentially blinding condition. The aim of this study is to survey common practice patterns and analyze the factors that affect ophthalmologists' management of ARN.

Methods: An anonymous survey was distributed to uveitis and retina specialists who are members of the American Uveitis Society (AUS) via email to query practice patterns regarding ARN. The survey included 22 questions with an additional 10 questions based on response. Survey question topics included demographic information, diagnostic testing, antiviral therapy, corticosteroids, and surgical procedures.

Results: 67 surveys were included for analysis. Most respondents (87%) always or frequently obtain intraocular aqueous fluid for diagnostic PCR testing. The majority of respondents would administer intravitreal antiviral injections to a unilateral immunocompetent ARN patient (67%), but would be even more likely to do so for a bilateral immunosuppressed ARN patient (87%). Respondents tend to treat ARN with systemic rather than local corticosteroids, with the majority (63%) of respondents initiating corticosteroid treatment 48 hours after treatment. Most respondents (79%) never perform a vitrectomy to manage ARN unless the patient has a retinal detachment or tear. The majority (63%) rarely or never perform prophylactic laser barricade, but may consider laser treatment if there is extensive retinal involvement.

Conclusion: Current practice patterns for diagnosis and management of ARN among AUS members generally align with the suggested practices outlined by the American Academy of Ophthalmology.

诊断和处理急性视网膜坏死的常见实践模式:葡萄膜炎专科医生调查研究。
目的:由于缺乏大型随机临床试验来确定治疗急性视网膜坏死(ARN)的最佳方法,眼科医生对如何最好地处理这种可能致盲的病症尚未达成明确共识。本研究旨在调查常见的实践模式,并分析影响眼科医生处理 ARN 的因素:我们通过电子邮件向美国葡萄膜炎协会 (American Uveitis Society, AUS) 成员中的葡萄膜炎和视网膜专家发放了一份匿名调查问卷,以询问有关 ARN 的实践模式。调查包括 22 个问题,另有 10 个问题根据答复而定。调查问题的主题包括人口统计学信息、诊断检测、抗病毒治疗、皮质类固醇激素和手术程序:共纳入 67 份调查问卷进行分析。大多数受访者(87%)总是或经常获取眼内水样液进行 PCR 诊断测试。大多数受访者会对单侧免疫功能正常的 ARN 患者(67%)进行玻璃体内抗病毒注射,但对双侧免疫抑制的 ARN 患者(87%)则更有可能这样做。受访者倾向于使用全身性皮质类固醇而非局部皮质类固醇治疗 ARN,大多数受访者(63%)在治疗 48 小时后开始使用皮质类固醇治疗。大多数受访者(79%)从不进行玻璃体切除术来治疗 ARN,除非患者出现视网膜脱离或撕裂。大多数受访者(63%)很少或从不进行预防性激光障眼法,但如果视网膜广泛受累,可能会考虑进行激光治疗:结论:澳大利亚眼科学会会员目前诊断和处理 ARN 的实践模式与美国眼科学会提出的建议基本一致。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
15.20%
发文量
285
审稿时长
6-12 weeks
期刊介绍: Ocular Immunology & Inflammation ranks 18 out of 59 in the Ophthalmology Category.Ocular Immunology and Inflammation is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and vision scientists. Published bimonthly, the journal provides an international medium for basic and clinical research reports on the ocular inflammatory response and its control by the immune system. The journal publishes original research papers, case reports, reviews, letters to the editor, meeting abstracts, and invited editorials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信